RankAlpha logo
Back to Rankings

FATE

Fate TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
FATE vs peer average
94/100
FATE vs. peer average (A vs. D)
Grade spread
A 1 · C 1 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

LYEL is the first available peer comparator.

Closest available candidate by sector and market capitalization, but the packet does not establish a direct operating, modality, or indication match with Fate; valuation read-through is limited.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLYELLyell Immunopharma
FATE
Fate Therapeutics
LYEL
Lyell Immunopharma
Grade
A
F
Momentum
95
8
Value
41
41
Sentiment
63
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs LYEL

FATE / LYEL
Grade Position
Above peers
FATE vs. peer average (A vs. D)
94/100
Momentum
95
FATE
Value
41
FATE
Sentiment
63
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs FATE
1
LYEL
LYEL
F
20/100
+4
2
ELDN
ELDN
F
20/100
+4
3
VNDA
Vanda Pharmaceuticals Inc Common
D
40/100
+3
4
SNDL
SNDL Inc Common
A
100/100
Even
5
PRLD
Prelude Therapeutics Inc Common
D
40/100
+3
LYEL is the first peer returned for this comparison set.